NCT06571747Active, not recruiting
Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement
Source: ClinicalTrials.gov · Last updated 15 May 2025
Brief summary (registry, in English)
In randomized clinical trials and observational studies, influenza vaccination is effective in reducing influenza-related illness and hospitalizations and potentially cardiovascular (CV) events and mortality in select populations. However, the potential population-level benefit of influenza vaccination is limited by its uptake. Novel implementation strategies to improve vaccination uptake are needed. KP VACCINATE is a multicenter, sequential, individual-level randomized controlled implementation trial examining the effectiveness of a CV-focused nudging communication vs. usual care communication on influenza vaccination uptake among Kaiser Permanente Northern California (KPNC) and Kaiser Permanente Mid Atlantic States (KPMAS) eligible members during the 2024-2025 influenza season.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 3668428 (actual)
- First submitted
- 22 Aug 2024
- Start date
- 5 Sept 2024
- Primary completion date
- 1 May 2025
- Lead sponsor
- Kaiser Permanente
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT06571747
What you commit to
- Study type: Interventional
- Participants enrolled: 3668428
- From 5 Sept 2024 to the primary completion date, 1 May 2025
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Unable to receive or opted out of receiving health system messaging
Other
- Other exclusion that prevents messaging outreach.
- Unknown service area or medical center affiliation.
Who the study is looking for
- Age ≥18 years
- Active KPNC or KPMAS member
- ≥6 months of continuous health plan coverage and prescription drug benefit before September 1, 2024
- Evidence of member access to the KP HealthConnect® Portal and/or a listed registered email address
- No documented influenza vaccination during the 2024-2025 influenza season prior to randomization
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaiser Permanente Mid Atlantic States Coordinator of this site? Confirm its status | Bethesda | United States | Unknown status |
| Kaiser Permanente Northern California Coordinator of this site? Confirm its status | Pleasanton | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.